Trial intelligence / Profile preview

Dicloxacillin added to topical mometasone for atopic dermatitis flare

2021-006883-25Phase 4Completed

Sponsor
Bispebjerg and Frederiksberg Hospital
Start
Apr 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of dicloxacillin and mometasone in atopic dermatitis (AD) (3 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Started Apr 2022; status: completed.

02

Drugs

dicloxacillinmometasone
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on 2021-006883-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-006883-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call